Trial Profile
Efficacy and safety of Exubera (inhaled insulin) therapy in subjects with type 2 diabetes mellitus not well controlled with combination oral agents: a three-month, outpatient, parallel comparative trial.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Pfizer
- 04 Oct 2006 New trial record.